
News|Articles|June 20, 2024
The Shift Toward Precision Medicine Requires Claims Data Insights
Author(s)PurpleLab
Healthcare today is evolving into precision medicine, or what the FDA refers to as personalized medicine. To stay competitive in the constantly shifting healthcare landscape, organizations across the healthcare ecosystem must embrace this targeted approach and leverage the tools needed to make safe decisions for their patients or populations. By unlocking insights provided from advanced claims data, precision medicine can assist clinicians, thereby reducing their educated guesses, improving patient outcomes, and making more informed decisions.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Trending on Applied Clinical Trials Online
1
Worldwide Clinical Trials to Acquire Catalyst Clinical Research, Expanding Oncology and FSP Capabilities
2
How Real-World Evidence Will Change Trials Without Replacing Them
3
ESG as a Quality System: Practical Steps to Embed Sustainability Into Vendor Oversight
4
What 2026 Will Demand From Clinical Operations: Rethinking Efficiency, Access, and AI
5